Aculeus Therapeutics

The startup develops drugs that modulate the immune system by targeting the stimulator of interferon genes (STING) pathway, which plays a crucial role in the body's response to cancer and serious diseases. This approach enhances the immune response, potentially improving treatment outcomes for patients with cancer.

Traction 3/10

Parkville, United States · HQ

Founded 20208500+ followers

Biotechnology

Updated 7 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

1 founder

Mark Devlin

CEO

Product

Features

The startup develops drugs that modulate the immune system by targeting the stimulator of interferon genes (STING) pathway, which plays a crucial role in the body's response to cancer and serious diseases. This approach enhances the immune response, potentially improving treatment outcomes for patients with cancer.